Nasdaq nstg.
NASDAQ NSTG opened at $0.50 on Thursday. The company has a market cap of $24.26 million, a P/E ratio of -0.14 and a beta of 1.67. NanoString Technologies has a 1 year low of $0.47 and a 1 year high of $13.20. The company has a current ratio of 2.73, a quick ratio of 2.02 and a debt-to-equity ratio of 16.67. The company has a fifty day simple ...
In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021. Financial Statements.Nov 20, 2023 · NanoString ( NASDAQ: NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance. On Friday ... NanoString Technologies (NASDAQ:NSTG) Full Year 2022 ResultsKey Financial Results. Revenue: US$127.3m (down 12% from FY 2021). Net loss: US$159.5m (loss widened by 38% from FY 2021).(NASDAQ: NSTG) Nanostring Technologies currently has 48,118,306 outstanding shares. With Nanostring Technologies stock trading at $0.55 per share, the total ...
NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...
EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission. Find the latest Financials data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com."NanoString Technologies, Inc. (NASDAQ:NSTG): NSTG is a leader in spatial biology, offering a platform of products that help researchers map biology down to a single-cell. Since our purchase of NSTG at the inception of the strategy nearly five years ago, the company has significantly widened its technology platform and products, …NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq ...
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported prelimi
Nasdaq | NSTG U.S.: Nasdaq NanoString Technologies Inc. Watch list After Hours Last Updated: Nov 21, 2023 7:56 p.m. EST Delayed quote $ 0.5000 0.00 0.06% After Hours Volume: 145.51K Advanced...
SEATTLE, January 08, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and ...SEATTLE, May 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported ...Surace-Smith, who is the senior vice president, human resources and legal affairs, of NanoString Technologies (NASDAQ: NSTG) has served on the board since 2014 and as the vice-chair since 2018. “Technology, finance, advancement, and innovation are critical to the lifesaving work done at Fred Hutch,” Surace-Smith said.NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S ...NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript. Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News, Transcripts. So if you really – if ...SEATTLE, July 15, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...As you can see below, at the end of June 2021, NanoString Technologies had US$224.4m of debt, up from US$167.3m a year ago. Click the image for more detail. But it also has US$398.0m in cash to ...
NanoString Technologies, Inc. Common Stock (NSTG) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript November 6, 2023 NanoString Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.78 EPS ...May 10, 2021 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights. Product and service revenue of $31.4 million, 28% year-over-year growth NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest NanoString Technologies Inc (NSTG) real-time quote, historical performance, charts, and other financial information to help you...SEATTLE, March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...
PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...Nanostring Technologies (NASDAQ: NSTG) is owned by 102.08% institutional shareholders, 56.27% Nanostring Technologies insiders, and 0.00% retail investors. Clarus Lifesciences Ii LP is the largest individual Nanostring Technologies shareholder, owning 6.07M shares representing 12.62% of the company.
SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript November 6, 2023 NanoString Technologies, Inc. misses on earnings expectations.Find the latest Earnings Report Date for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com. Fintel reports that on November 21, 2023, Baird downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Outperform to Neutral . Analyst Price Forecast Suggests 1,436.84% Upside As ...NanoString Technologies (NASDAQ:NSTG) Q4 2013 Earnings Conference Call February 26, 2014 4:30 PM ETExecutives. Lynn Pieper - Managing Director, Westwicke Partners LLC. Bradley Gray - President and ...SEATTLE, February 23, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management ...
Find the latest news headlines from NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.
Nov 20, 2023 · NanoString (NASDAQ:NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance.On Friday, 10x ...
NanoString Technologies, Inc. (NASDAQ:NSTG) shares dropped 47% to $0.6782. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.NanoString Technologies, Inc. Common Stock (NSTG) Nasdaq Listed. CLOSED AT 4:00 PM ET ON Jun 06, 2022. DATA AS OF Jun 06, 2022 7:59 PM ET - AFTER HOURS. 0. No Notifications. Add to Watchlist.SEATTLE, Jan. 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...NanoString Technologies last posted its earnings results on November 6th, 2023. The biotechnology company reported ($0.78) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.25. The company had revenue of $48.09 million for the quarter, compared to analyst estimates of $46.05 million.Nov 20, 2023 · NanoString ( NASDAQ: NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance. On Friday ... Average. $4.86. Current Price. $0.55. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ... A. The latest price target for NanoString Technologies ( NASDAQ: NSTG) was reported by Baird on Tuesday, November 21, 2023. The analyst firm set a price target for 0.75 …Nov 28, 2023 · NanoString Technologies has a one year low of $0.47 and a one year high of $13.20. The firm has a market capitalization of $26.74 million, a PE ratio of -0.16 and a beta of 1.67. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73. NanoString Technologies ( NASDAQ:NSTG – Get Free Report) last ... NanoString Technologies Inc (NASDAQ:NSTG) 0.4957 Delayed Data As of Nov 30 -0.0069 / -1.37% Today’s Change 0.47 Today ||| 52-Week Range 13.20 -93.78% Year-to-Date Quote Profile News Charts...In a surprising turn of events on November 21, 2023, NanoString Technologies (NASDAQ:NSTG) found itself facing a downgrade from Baird analyst Catherine Ramsey. The once highly regarded company was downgraded from an Outperform rating to Neutral, with the price target plummeting from $4 to a mere $0.75. …
Find the latest Earnings Report Date for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.Price Action: TXG shares are up 4.02% at $54.65, and NSTG shares are down 20.60% at $6.76 on the last check Thursday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free!NanoString Technologies (NSTG) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.64 per share a year ago.SEATTLE, January 19, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new ...Instagram:https://instagram. stock gainers and losersforex sitesnifty beesdental insurance for dentures Nov 7, 2023 · NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript. Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News, Transcripts. So if you really – if ... The NSTG stock price is -964.52% off its 52-week high price of $13.20 and 17.74% above the 52-week low of $1.02. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.09 million shares traded. The 3-month trading volume is 1.44 million shares. Nanostring Technologies Inc (NASDAQ:NSTG) trade information auto desk stockwhat companies are in the dow SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights. Product and service revenue of $31.4 million, 28% year-over-year growthNSTG NASDAQ. NSTG NASDAQ. NSTG NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 4.86 0.00 0.00%. The 6 analysts offering 1 year price forecasts for NSTG have a max estimate of — and a min estimate of —. Analyst rating. chip makers stock 15,975.75 -33.00(-0.21%) Russell 2000 Futures 1,799.60 -4.60(-0.25%) Crude Oil 75.03 +0.17(+0.23%) Gold 2,017.10 +4.70(+0.23%) Advertisement NanoString Technologies, Inc. (NSTG) NasdaqGM -...9h. JP Morgan has downgraded NanoString ( NASDAQ: NSTG) to neutral due to limited near-term visibility amid ongoing patent litigation. The investment bank noted that NanoString is embroiled in ...ORLANDO, Fla., Feb. 27, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...